Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Global hepatitis drugs market could be boosted by experimental drug from Abbott Laboratories

Global hepatitis drugs market could be boosted by experimental drug from Abbott Laboratories


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-10-19 17:59:58 - Global hepatitis drugs market could be boosted by experimental drug from Abbott Laboratories

The global hepatitis drugs market has been forecast to increase at a compound annual growth rate (CAGR) of 12.42% through to 2015, driven by the increase in demand for hepatitis drugs in developing countries along with the increase in the number of mergers and acquisitions.However, the shortage of hepatitis drugs to meet market demand could pose a challenge to the growth of this market.Vendors are increasingly forming strategic alliances with other vendors to market their manufactured drugs to acquire a wider market share in the Global Hepatitis Drugs market. For instance Merck and Co. Inc. has formed a partnership with Roche Holding Ltd. to market its hepatitis drugs to increase its market share. Similarly, Vertex Pharmaceuticals Ltd. has a partnership

 

 

with Johnson and Johnson Services Inc. to market its hepatitis drugs outside the US.Key companies dominating the hepatitis drugs market include Abbott Laboratories, Bristol-Myers Squibb Co., Gilead Sciences Inc., GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Merck & Co. Inc.An experimental drug combination has just been released by Abbott Laboratories which wiped out all traces of the virus that causes hepatitis C in 99% of patients with the liver disease.The 571 patients in the trial took a two- or three-drug mixture of Abbott therapies for 8 to 24 weeks, along with the antiviral ribavirin. A 79-patient group on the combination of three medicines plus ribavirin for 12 weeks responded best.For more information on the global hepatitis drugs market, see the latest research: Global Hepatitis Drugs MarketFollow us on Twitter @CandMResearch

Click for news details: www.companiesandmarkets.com/News/Healthcare-and-Medical/Global-h ..

Browse all Healthcare and Medical C&M News www.companiesandmarkets.com/News/Healthcare-and-Medical/?aCode=f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser